- The Trump administration will end a temporary Medicare Part D premium subsidy in 2027, a move expected to raise prescription drug insurance costs for millions of older Americans.
- The Centers for Medicare & Medicaid Services says the program, introduced to stabilize premiums, will expire after costing the federal government about $3.6 billion a year.
- Roughly 25 million Medicare beneficiaries benefited from the subsidy, which lowered monthly premiums by an average of $16.
- Health policy experts warn some seniors could see their monthly drug plan premiums jump by as much as $20, with higher costs potentially pushing more people into Medicare Advantage plans.
- The decision comes as many Americans continue to grapple with rising healthcare costs, creating a potential political headache for President Donald Trump as he tries to maintain support among older voters.
IN FULL
Older Americans set to see Medicare cost rise after Trump kills subsidy for drug program
